bis-(7)-tacrine

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebis-(7)-tacrine
Drug Alias NameGABA A receptor antagonist/acetylcholinesterase inhibitor (Mayo foundation/Hong kong university of Science and Technology)NMDA receptor antagonist/nitric oxide synthase inhibitor (Mayo foundation/Hong kong University)bis-(12)-huperinebis-THA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonistsNitric oxide synthase inhibitorsGlutamate [NMDA] receptor antagonists +[4] 
TargetsNitric oxide synthaseAcetylcholinesteraseGamma-aminobutyric acid A receptor +[4] 
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHong Kong University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHong Kong University Of Science And TechnologyMayo Clinic
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A